All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Clinical comparison

Macimorelin (Macrilen) vs Octreotide (Sandostatin)

An educational, source-based comparison of Macimorelin (Macrilen) and Octreotide (Sandostatin) — how each peptide works, what it's researched for, and what to know before going deeper.

GH Secretagogue · Diagnostics
Macimorelin (Macrilen)

Oral ghrelin agonist for diagnosing adult growth hormone deficiency.

Mechanism

Oral ghrelin receptor (GHSR-1a) agonist that stimulates pituitary GH release; peak GH response is measured to evaluate adult GH deficiency.

Research areas
  • Diagnostic test for adult GH deficiency
Considerations
  • FDA-approved.
  • Avoid with QT-prolonging drugs.
  • Hold strong CYP3A4 inducers prior to test.
Full Macimorelin (Macrilen) profile →
Somatostatin Analog · Oncology
Octreotide (Sandostatin)

Synthetic somatostatin analog for acromegaly and neuroendocrine tumors.

Mechanism

An 8-amino-acid synthetic analog of somatostatin that binds somatostatin receptors (primarily SSTR2 and SSTR5), suppressing growth hormone, glucagon, insulin, and several gastrointestinal hormones. Longer half-life than native somatostatin enables therapeutic use.

Research areas
  • Acromegaly
  • Carcinoid syndrome
  • VIPomas
  • Variceal bleeding
  • Neuroendocrine tumors
Considerations
  • FDA-approved.
  • Gallstones, hyperglycemia, GI upset are common adverse effects.
Full Octreotide (Sandostatin) profile →

Macimorelin (Macrilen) vs Octreotide (Sandostatin) — Key differences

  • Class: Macimorelin (Macrilen) is classified as GH Secretagogue · Diagnostics, while Octreotide (Sandostatin) is Somatostatin Analog · Oncology.
  • Primary research focus: Macimorelin (Macrilen)diagnostic test for adult gh deficiency; Octreotide (Sandostatin)acromegaly.
  • Tag: FDA-Approved · Diagnostics vs FDA-Approved · Endocrine.

Related comparisons